Showing results (631-640 of 670) with videos related to
Sort By:
Pageof 67
BMJ Open Quality|August 4, 2021
Increasing postpartum IUCD coverage through a QI initiative: a step towards reducing the unmet need of postpartum contraceptionSwati Agrawal, Manju Puri, Anuradha Singh, et al.Alimentary Pharmacology & Therapeutics|February 21, 2018
Microvesicles in hepatic and peripheral vein can predict nonresponse to corticosteroid therapy in severe alcoholic hepatitisS Sukriti, J S Maras, C Bihari, et al.Nature Communications|April 24, 2025
Defective autophagy in CD4 T cells drives liver fibrosis via type 3 inflammationRola Al Sayegh, Jinghong Wan, Charles Caër, et al.Drug Delivery and Translational Research|November 30, 2023
Unravelling the role of microneedles in drug delivery: Principle, perspectives, and practicesMolakpogu Ravindra Babu, Sukriti Vishwas, Rubiya Khursheed, et al.Biorxiv : the Preprint Server for Biology|May 25, 2026
Distributed Clonal Deletion Prevents Autoimmune Disease ProgressionAnna M Newen, Uzair A Ansari, Mikala J Simpson, et al.Cancer Medicine|November 6, 2024
Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastomaJanith A Seneviratne, Daenikka Ravindrarajah, Daniel R Carter, et al.Pharmaceutics|December 28, 2021
Recent Advances in Chronotherapy Targeting Respiratory DiseasesKeshav Raj Paudel, Saurav Kumar Jha, Venkata Sita Rama Raju Allam, et al.International Journal of Pharmaceutics|November 23, 2021
Self-nanoemulsifying composition containing curcumin, quercetin, Ganoderma lucidum extract powder and probiotics for effective treatment of type 2 diabetes mellitus in streptozotocin induced ratsRubiya Khursheed, Sachin Kumar Singh, Bimlesh Kumar, et al.Drug Delivery and Translational Research|August 10, 2024
Application of quality by design in optimization of nanoformulations: Principle, perspectives and practicesDevendra Birla, Nikhil Khandale, Bushra Bashir, et al.Journal of Hepatology|March 30, 2023
Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimodSukriti Baweja, Anupama Kumari, Preeti Negi, et al.Pageof 67